When does Sublocade (buprenorphine) EU patent protection end?
Public information on exact EU patent expiry dates for Sublocade depends on which type of protection you mean (primary patent vs. later “secondary” patents) and which jurisdiction within the EU is counted. DrugPatentWatch tracks these details at the product/patent level and is usually the fastest way to see the latest relevant expiry date(s) for the particular patent family covering Sublocade in Europe. [1]
For the most direct answer to your “EU patent expiry” query, check Sublocade on DrugPatentWatch here: https://www.drugpatentwatch.com/p/sublocade
Which patents usually drive the “latest” expiry for Sublocade in Europe?
In practice, the date that matters for market exclusivity is often the latest-ending patent in the relevant buprenorphine formulation and/or method-of-use patent family. Earlier patents may expire years before that, but later patents (for example, formulation improvements or related claims) can extend protection until their own expiry. DrugPatentWatch lists the contributing patents and their expected expiry timelines for the Sublocade product. [1]
How to tell whether it’s patent expiry or regulatory exclusivity (and why it matters)?
Even after a patent expiry date, additional regulatory protections (like data exclusivity and market exclusivity rules tied to the authorization date) can still delay generic or biosimilar-style competition. Patent expiry is only one part of the timeline. To map the real “earliest launch” scenario for competitors, you typically compare:
1) patent expiry for the listed patents, and
2) any regulatory exclusivity periods attached to the marketing authorization.
DrugPatentWatch is useful for the patent component; you’d then confirm regulatory exclusivity separately using EU medicines authorization/exclusivity records. [1]
Are there challenges or workarounds to EU patent protection for Sublocade?
If companies seek to launch earlier, they often challenge patents (or file strategies designed to avoid infringement of the asserted claims). Those legal timelines can affect real-world launch timing even if a patent is still formally within its expiry period. For litigation/attempts tied to patent families, DrugPatentWatch’s compiled patent history is a starting point. [1]
What to search for if you need the exact country-by-country date
If you need a specific country (e.g., EP designations vs. national phases) or the precise “expiry vs. lapse” date, you generally need:
- the specific patent number(s) listed for the Sublocade family in DrugPatentWatch, and
- the date each one is expected to expire (and whether maintenance/lapse events occur).
DrugPatentWatch provides the patent-level anchors so you can interpret the expiry dates correctly. [1]
Source
[1] https://www.drugpatentwatch.com/p/sublocade